Patent Assignment
Reel/Frame 060156/0901
Security Interest
Recorded: 2022-06-10
Pages: 13
Assignors
EIGER BIOPHARMACEUTICALS, INC.
Executed: 2022-06-01
EB PHARMA, LLC
Executed: 2022-06-01
EBPI MERGER, INC.
Executed: 2022-06-01
Assignee
INNOVATUS LIFE SCIENCES LENDING FUND I, LP
777 THIRD AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties
(22)
Method and device for editing the moving path of a multimedia object
Application:
10/076,512 →
Publication:
US 2002/0113794
Volume Management Method and Apparatus
Vehicles and control systems thereof with adjustable steering axes
Application:
10/953,072 →
Publication:
US 2005/0154504
Musical Instrument Tuner
Patent:
7,285,710 →
Application:
11/311,519 →
Pharmaceutical Compositions Comprising Lonafarnib and Ritonavir
Treatment of Hyperinsulinemic Hypoglycemia with Exendin-4 Derivatives
Methods and Pharmaceutical Compositions for the Treatment of Non-Alcoholic Steatohepatitis
Buffered Formulations Of Exendin (9-39)
Methods and Pharmaceutical Compositions for the Treatment of Non-Alcoholic Steatohepatitis
Application:
16/768,000 →
Publication:
US 2021/0369693
Methods for the Treatment of Non-Alcoholic Steatohepatitis
Treatment of Hyperinsulinemic Hypoglycemia with Exendin-4 Derivatives
Methods of Treating Hepatitis Delta Virus Infection
Treatment of Hepatitis Delta Virus Infection with Interferon Lambda
Treatment of Hepatitis Delta Virus Infection
Application:
17/197,687 →
Publication:
US 2022/0023287
Treatment of Hepatitis Delta Virus Infection with Interferon Lambda
Application:
17/268,657 →
Publication:
US 2021/0187073
Avexitide for the Treatment of Hyperinsulinemic Hypoglycemia
Application:
17/285,039 →
Publication:
US 2021/0338780
Methods of Using Buffered Formulations of Exendin (9-39)
Compositions of Exendin-4 Derivatives
Application:
17/398,551 →
Publication:
US 2021/0369814
Treatment of Hepatitis Delta Virus Infection
Method of Treating Laminopathies
Application:
17/699,725 →
Methods to Treat Hepatitis Delta Viral Infections
Application:
17/754,587 →
Publication:
US 2024/0082360
Treatment of Congenital Hyperinsulinism with Avexitide
Application:
63/213,051 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
License
Feb 8, 2005
From: FENELLI, NICHOLAS E.
To: AIRTRAX, INC.
Reel/Frame 016548/0064 →
Security Agreement
Feb 21, 2007
From: AIRTRAX, INC.
To: SPENCER, RICHARD LEE, JR.; UNITY CAPITAL; UNBEATABLE TRADING, INC.; SHEARER, WILFRED L.
Reel/Frame 018917/0089 →
Assignment of Assignor's Interest
Sep 4, 2018
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 046781/0234 →
Assignment of Assignor's Interest
Jan 3, 2020
From: XIONG, XIAOFENG; CORY, DAVID A.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 051414/0108 →
Assignment of Assignor's Interest
Feb 5, 2020
From: XIONG, XIAOFENG; CORY, DAVID A.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 051724/0890 →
Assignment of Assignor's Interest
Apr 17, 2020
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 052433/0164 →
Assignment of Assignor's Interest
Jun 3, 2020
From: GOSSELIN, PATRICK; BETANCOURT, AIMESTHER
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 052825/0129 →
Assignment of Assignor's Interest
Jun 25, 2020
From: CORY, DAVID
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 053926/0912 →
Assignment of Assignor's Interest
Oct 21, 2020
From: GOSSELIN, PATRICK; BETANCOURT, AIMESTHER
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 054124/0182 →
Assignment of Assignor's Interest
Feb 18, 2021
From: MARTINS, EDUARDO BRUNO
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 055326/0364 →
Assignment of Assignor's Interest
Mar 10, 2021
From: CORY, DAVID; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 055551/0607 →
Assignment of Assignor's Interest
Mar 16, 2021
From: CHOONG, INGRID; MARTINS, EDUARDO BRUNO
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 055609/0436 →
Assignment of Assignor's Interest
Mar 19, 2021
From: MCLAUGHLIN, TRACEY L.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 055657/0319 →
Assignment of Assignor's Interest
May 3, 2021
From: XIONG, XIAOFENG; ODINK, DEBRA; SMITH, CHRISTINE M.N.; CRAIG, COLLEEN M.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 056120/0084 →
Assignment of Assignor's Interest
May 3, 2021
From: MCLAUGHLIN, TRACEY L.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 056120/0107 →
Assignment of Assignor's Interest
Aug 11, 2021
From: XIONG, XIAOFENG
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 057146/0827 →
Assignment of Assignor's Interest
Sep 28, 2021
From: PORTER, LISA; CRAIG, COLLEEN M.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 057632/0818 →
Assignment of Assignor's Interest
Mar 30, 2022
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 059438/0266 →
Assignment of Assignor's Interest
Aug 14, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068284/0396 →
Assignment of Assignor's Interest
Aug 14, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068283/0933 →
Assignment of Assignor's Interest
Aug 14, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068284/0280 →
Assignment of Assignor's Interest
Sep 24, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068683/0015 →
Assignment of Assignor's Interest
Sep 30, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: EIGER INNOTHERAPEUTICS, INC.
Reel/Frame 068746/0913 →
Assignment of Assignor's Interest
Dec 6, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: EIGER INNOTHERAPEUTICS, INC.
Reel/Frame 069514/0081 →
Change of Name
Feb 5, 2025
From: EIGER INNOTHERAPEUTICS, INC.
To: EIT PHARMA, INC.
Reel/Frame 070125/0766 →